Yimaikang Tablet

  • Brief Infomation:
  • Yimaikang Tablet is extracted and isolated from Erigerontis Herba, a traditional Chinese herbal medicine in Yunnan Province, and used for the treatment of cardiovascular and cerebrovascular diseases. It is used for paralysis after ischemic cerebrovascular disease and cerebral hemorrhage, fundus retinal vein occlusion, coronary heart disease, vascular dermatoses and rheumatism. Yimaikang Tablet can improve cerebrovascular circulation, increase cerebral and cardiac blood flow, improve myocardial ischemia and hypoxia tolerance, dilate peripheral blood vessels, improve skin capillary permeability and increase local tissue blood flow, and improve microcirculation.

  • Font size: Large middle Small
  • Read: 1340
  • Yimaikang Pian


    Yimaikang tablets


    This product is extracted and isolated from Erigerontis Herba, it can promote blood circulation and remove blood stasis. It is indicated for ischemic cerebrovascular disease and paralysis after cerebral hemorrhage, fundus retinal vein occlusion, coronary heart disease, vasculitic dermatosis, and rheumatism.


    Strength: 0.31 g/tablet (containing 40 mg of total flavonoids)


    Dosage and administration: Oral, 2 tablets/time, 3 times daily


    Adverse reactions: Uncertain.


    Contraindications: Uncertain.


    Warnings and Precautions: uncertain


    Storage: sealed and protected from light.


    Package: Aluminum-plastic blister package, 12 tablets/plate, 2 plates/box

     

    Shelf life]:36 Months


    Reference specification: WS3-B-2410-97-1


    Approval No.: SFDA Approval No. Z53020265


    Marketing Authorization Holder: Company Name: Kunming Sinoway Pharmaceutical Co.Ltd..